Z-(R,S)-3-amino-5-cyclohexyl-2-oxo-1,4-benzodiazepine, 99.0%, 250mg

N-((4aR,6S,7R,8R,8aS)-6-(Benzyloxy)-8-hydroxy-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-7-yl)acetamide, 95.0%, 1g

(S)-tert-Butyl (1-cyclohexyl-2-hydroxyethyl)carbamate, 95.0%, 100g

Sodium 2-(1H-indol-3-yl)acetate, 95.0%, 25g

2,2-Difluorocyclopropylamine hydrochloride, 97.0%, 100g

Benzoylacetonitrile>98.0%(GC)25g

((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate, 97%, 5g

4-Chloronicotinamide, 97.0%, 1g

Disodium oxalate, min. 99.5%, pa, ACS, 100 g, plastic packaging.

(2,3-Dichloro-4-pyridinyl)methanol, 95+%, 5g

2-Chloro-N,N-dicyclohexyl-acetamide, 99%, 500mg

2,2'-((tert-Butoxycarbonyl)azanediyl)diacetic acid, 95.0%, 100g

5-Chloro-isatoic anhydride, 97.0%, 10g